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Ashley M. Fox, Faruk H. Moonschi, and Christopher I. Richards1
From the Department of Chemistry, University of Kentucky, Lexington, Kentucky 40506
Background: Nicotine-induced changes in nAChRs are linked to nicotine addiction.
Results: Cotinine, the primary metabolite of nicotine, alters the assembly and expression of some subtypes of nAChRs.
Conclusion: Cotinine affects trafficking and assembly of a subset of nAChRs.
Significance: Cotinine has a much longer half-life in the body than nicotine, and therefore may contribute to physiological
effects attributed to nicotine.

Nicotinic acetylcholine receptors (nAChRs)2 are cation-selective ligand-gated ion channels that express throughout the
central and peripheral nervous systems. They form pentameric
structures composed of ␣ (␣2-␣10) and ␤ (␤2-␤4) subunits,
with each subunit encoded by a distinct gene (1–3). Receptor
assembly into the correct stoichiometry and composition is
essential for proper subcellular localization, agonist sensitivity,
and Ca2⫹ permeability (4, 5). Nicotine, the primary addictive
component in tobacco, binds to and activates nAChRs. Beyond
eliciting a functional response, nicotine has been shown to upregulate some nAChR subtypes including those composed of
␣4 and ␤2 subunits. Up-regulation has been defined as changes
in stoichiometry, distribution, or increased number of nAChRs
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(6 –9) and has been established as one of the consequences of
chronic nicotine exposure (7, 8, 10 –12). Nicotine-induced
changes in nAChRs have been proposed as a potential component in the mechanism for nicotine addiction (8, 13–17). The
current pharmacological chaperoning hypothesis suggests that
these changes only require concentrations of nicotine to be
high enough to interact with the specific subtype in the endoplasmic reticulum, meaning surface activation is not required
(8, 18) Other nAChR ligands, including drugs that have been
evaluated as smoking cessation agents, have also been shown to
up-regulate nAChRs. These drugs include the partial agonists
cytisine (19) and varenicline (20) as well as the antagonist
mecamylamine (21). Although nicotine exposure increases the
assembly of the high sensitivity receptor, (␣4)2(␤2)3 (16, 22),
cytisine has been shown to alter the stoichiometry of ␣4␤2 with
a preference for the low sensitivity receptor, (␣4)3(␤2)2, potentially due to the existence of an additional binding site for cytisine at the ␣-␣ interface (23, 24). The high and low sensitivity
stoichiometries of ␣4␤2 exhibit different ligand binding affinities and Ca2⫹ flux and desensitize at different rates (5, 9). These
differences, along with the increased expression of the high
sensitivity stoichiometry, are believed to contribute to nicotine
addiction (8, 25, 26).
In humans, ⬃80% of nicotine is metabolized to cotinine,
which has a much longer pharmacological half-life (24 h) than
nicotine (2 h) (27, 28). Nicotine and cotinine are very similar in
structure, varying by only an acetyl group (29). Cotinine is also
known to cross the blood-brain barrier (30), where it acts as a
partial agonist to nAChRs (31). Studies have shown that cotinine improves learning, memory, and attention as well as
enhances cognition and executive function (29, 32). Additionally, cotinine exposure on its own has not been shown to lead to
addictive behavior or to the negative cardiovascular effects
associated with nicotine (33). As a result, cotinine has generated interest as a pharmacologically active compound, with a
few recent studies that examine the effect of cotinine on
nAChRs (32, 34, 35). Terry et al. (34) recently found that 1 M
cotinine in combination with low levels of acetylcholine sensitized ␣7 nAChRs, resulting in increased channel activity as
compared with acetylcholine alone. They also found that 10 M
cotinine exposure for 48 h led to a slight down-regulation of
␣4␤2 in a Xenopus laevis oocyte expression system (34). Here
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Exposure to nicotine alters the trafficking and assembly of
nicotinic receptors (nAChRs), leading to their up-regulation on
the plasma membrane. Although the mechanism is not fully
understood, nicotine-induced up-regulation is believed to contribute to nicotine addiction. The effect of cotinine, the primary
metabolite of nicotine, on nAChR trafficking and assembly has
not been extensively investigated. We utilize a pH-sensitive variant of GFP, super ecliptic pHluorin, to differentiate between
intracellular nAChRs and those expressed on the plasma membrane to quantify changes resulting from cotinine and nicotine
exposure. Similar to nicotine, exposure to cotinine increases the
number of ␣4␤2 receptors on the plasma membrane and causes
a redistribution of intracellular receptors. In contrast to this,
cotinine exposure down-regulates ␣6␤2␤3 receptors. We also
used single molecule fluorescence studies to show that cotinine
and nicotine both alter the assembly of ␣4␤2 receptors to favor
the high sensitivity (␣4)2(␤2)3 stoichiometry.

Cotinine-induced Changes in nAChRs
we utilize a combination of super ecliptic pHluorin-based fluorescence imaging and single molecule measurements to show
that although high concentrations of cotinine (⬎5 M) do not
increase receptor expression on the plasma membrane, lower
concentrations of cotinine alter both the assembly and the trafficking of nAChRs.
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Experimental Procedures
Reagents—(⫺)Cotinine and (⫺)-nicotine hydrogen tartrate
salt were obtained from Sigma-Aldrich.
Nicotinic Receptor Plasmid Constructs—All constructs were
preassembled as described previously (36). All subunit plasmids
are of mouse origin. Super ecliptic pHluorin (SEP) fluorophores
were incorporated on the C terminus of ␣4 and ␣6 subunits.
GFP fluorophores were incorporated into the M3-M4 loop of
the ␣4 subunit. All plasmids assemble normally and have been
used in previous studies (14, 36). Plasmids containing nAChRs
labeled on the C terminus with SEP have previously been shown
to be functional based on whole cell patch clamp studies (7, 22,
36). The QuikChange II XL site-directed mutagenesis kit was
used to create the ␣5-D398N mutation commonly associated
with an increase in risk of smoking and lung cancer. The D398N
corresponds to an aspartic acid to asparagine change in position
397 in the mouse plasmid (37).
Cell Culture and Transfection—Undifferentiated mouse neuroblastoma 2a (N2a) cells were cultured using standard tissue
culture techniques and maintained in growth media consisting
of DMEM and Opti-MEM, supplemented with 10% fetal bovine
serum, penicillin, and streptomycin (19, 36). Cells were plated
by adding 90,000 cells to poly-D-lysine-coated 35-mm glass bottom dishes (In Vitro Scientific). The following day, growth
medium was replaced with Opti-MEM for cell transfection.
Cells were transfected with 500 ng of each nAChR subunit plasmid mixed in 250 l of Opti-MEM. A separate aliquot of 2 l of
Lipofectamine-2000 and 250 l of Opti-MEM was incubated at
room temperature for 5 min and then combined with the plasmid solution for an additional 25 min before being added to
pre-plated N2a cells. After 24 h at 37 °C, the transfection mixture was replaced with growth media and incubated for an additional 24 h at 37 °C before imaging. For drug-exposed cells, the
indicated concentration of the appropriate drug was added at
the time of the transfection and replenished in the growth
medium replacement for a total of 48 h of exposure before
imaging. Transfection efficiency was ⬃80% and was not influenced by the presence of a drug.
Total Internal Reflection Fluorescence Microscopy (TIRFM)—
Samples were imaged with objective style total internal reflection fluorescence microscopy with an inverted fluorescence
microscope (Olympus ix83). TIRFM allows the excitation of
fluorophores within ⬃100 –200 nm from the cell-glass bottom
dish interface, visualizing receptors localized to the plasma
membrane or peripheral endoplasmic reticulum (38). SEP was
excited with a 488-nm diode-pumped solid-state laser (⬃1.00
watt/cm2) through the objective (Olympus, 1.49NA, 60⫻ oil
immersion) and detected by an electron-multiplying charge
coupled device (Andor iXon Ultra 897). To obtain total internal
reflection, the laser was focused on the back aperture of the
objective lens and the angle was adjusted using a stepper motor

to translate the beam laterally across the objective lens. Due to
low excitation intensity, photobleaching is not an issue on the
timescale of these measurements.
Measuring Receptor Expression and Trafficking—The pH
sensitivity of SEP was utilized to determine subcellular location
within the TIRF field. SEP undergoes 488 nm excitation at neutral pH but is dark under acidic conditions of pH ⬍ 6 (39),
allowing us to differentiate between intracellular and inserted
nAChRs. The SEP tag is fused with the C terminus of the
nAChR subunit so that it is exposed to the pH on the luminal
side of the organelles within the secretory pathway. Before
imaging, growth medium was exchanged for extracellular solution (150 mM NaCl, 4 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 10 mM
HEPES, and 10 mM glucose) adjusted to pH 7.4. Receptors in the
ER (pH ⬎ 7) and on the PM (pH of extracellular solution, 7.4)
are visible, whereas those in the lower pH environments of the
Golgi and secretory vesicles are not fluorescent (36, 40). After
images were collected at pH 7.4, the solution was exchanged
with an otherwise identical solution adjusted to pH 5.4. When
the pH of the extracellular solution is ⬍6, nAChRs located on
the PM transition into the off state, so the observed fluorescence is solely from nAChRs in the peripheral ER (7, 38, 41).
The integrated density of TIRF images, showing the relative
number of fluorescent receptors, are collected at both pH 7.4
and pH 5.4. The integrated density at pH 5.4 is subtracted from
the total integrated density of fluorophores in the ER and on the
PM shown at pH 7.4 to determine the integrated density of
receptors on the plasma membrane (PMID). The ratio of
receptors on the plasma membrane (% PM) is the PMID
divided by the total integrated density at pH 7.4 to provide a
ratio of receptors within the TIRF view that reside on the
membrane. Increased PMID reflects an up-regulation in
the number of receptors found on the PM. An increase in the
percentage of receptors found on the plasma membrane
(% PM) corresponds to a change in the distribution of receptors between the ER and PM.
Real time images were acquired at a frame rate of 200 ms for
1500 frames to capture fusion of nAChR-containing transport
vesicles with the plasma membrane. These studies enable us to
identify changes in the number of vesicles that contain nAChRs
but not in the total number of vesicles. Insertion events were
manually counted per cell during a randomly chosen 50 frames
(10 s). Insertion events were defined as a burst of fluorescence at
the PM lasting at least 2 frames (400 ms) and including lateral
spreading of fluorophores to ensure transient full fusion of the
vesicle and delivery of nAChRs to the membrane. Persistent,
continuously repeating bursts of fluorescence were not counted
because a discrete exocytic event could not be guaranteed.
Receptor Expression Data Analysis—Quantification of fluorescence intensity was determined using ImageJ (National
Institutes of Health) by manually selecting an intensity-based
threshold and region of interest. All figures show results from a
single imaging session that are representative of data collected
on at least three separate occasions. All graphs show the mean
with error bars representing S.E. p values were determined
using a two-tailed t test with equal variance not assumed.
Stoichiometric Determination—Vesicles were prepared from
HEK-293T cells expressing ␣4-gfp/␤2-wt as described previ-
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F 共 k, n, p 兲 ⫽

n!
p k共 1 ⫺ p 兲 n ⫺ k
k! 共 n ⫺ k 兲 !

(Eq. 1)

where n is the total number of labeled subunits, k is the number
of observed units, p is the probability of GFP being in an observable state, and F is the probability of observing k number of
photobleaching steps from n number of labeled subunits. Modeling the probability of observing a specific number of photobleaching steps for ␣4␤2 requires two binomial distributions
(Eq. 2) for k ⫽ 1, 2, and 3 for both F1 and F2. F1 corresponds to
the case when n1 GFP-labeled subunits are in a receptor, and F2
OCTOBER 2, 2015 • VOLUME 290 • NUMBER 40

corresponds to the case when there are n2 GFP-labeled subunits
in a receptor.
F tot ⫽ a1 ⫻ F1 共k, n1, p兲 ⫹ a2 ⫻ F2 共k, n1, p兲

(Eq. 2)

Results
Up-regulation of ␣4␤2 Receptors—We used SEP, a pH-sensitive variant of GFP (36, 39, 45), to quantify the up-regulation of
␣4␤2 nAChRs in the presence of nicotine and cotinine. SEP
undergoes 488 nm excitation and exhibits green fluorescence at
neutral pH but is not fluorescent under acidic conditions of
pH ⬍ 6 (39). We exposed N2a cells expressing ␣4-sep and
␤2-wt subunits to cotinine concentrations ranging from 50 nm
to 10 M. Fig. 1 shows representative TIRF images of N2a cells
expressing ␣4-sep ␤2-wt treated with no drug (Fig. 1A), 500 nM
nicotine (Fig. 1B), or 1 M cotinine (Fig. 1C). For all rows, the
first column shows a cell imaged in TIRF with an extracellular
pH of 7.4 (ER and PM fluorescing), the second column shows an
image of the same cell at pH 5.4 (fluorescence from ER only),
and the third column shows a subtracted image representing
just the PM component. Although the subtracted TIRF footprint shown in the third column qualitatively shows PM expression for the given cells, the extent of up-regulation was quantified by calculating the PMID of ␣4␤2 receptors with and
without cotinine. Distribution of ␣4␤2 receptors within the cell
are compared using percentage of plasma membrane (% PM),
calculated by dividing the PM integrated density, determined
from the difference between pH 7.4 and pH 5.4 images, by the
total integrated density of receptors fluorescing on the PM and
ER at pH 7.4. Increased expression on the plasma membrane
was observed when cells were treated with as little as 100 nM
cotinine, showing a 50% increase in number of receptors on the
membrane (Fig. 2A; p ⬍ 0.05), as well as a 25% shift in the
distribution (% PM) of receptors toward the membrane (Fig.
2B; p ⬍ 0.01). The highest levels of up-regulation were reached
in the presence of 1 M cotinine, resulting in more than a 2-fold
increase in PMID (Fig. 2A; p ⬍ 0.001) and over a 50% shift in
distribution toward the PM (Fig. 2B; p ⬍ 0.001). Exposure to 5
M cotinine showed an increase over no drug, but the effect was
much less than observed with 1 M. Exposure to 10 M cotinine
did not result in an increase in the number of receptors on the
PM (Fig. 2A), although the distribution of receptors at 10 M
slightly favors the PM (Fig. 2B; p ⬍ 0.05).
Cotinine Increases Number of ␣4␤2 Insertion Events—We
utilized SEP-tagged nAChRs to quantify nAChR-containing
vesicle trafficking by measuring the number of vesicle insertion
events at the plasma membrane. The SEP tag is oriented on the
luminal side of secretory vesicles so that they are maintained at
a low pH prior to delivery to the PM. As a result, receptors are
not fluorescent as they are trafficked to the PM but turn on as
the vesicle fuses with the PM, when the SEP tag is exposed to the
extracellular solution (pH 7.4) (39, 45). We defined an insertion
event as a burst of fluorescence appearing at the plasma membrane, which corresponds to membrane insertion of an SEPtagged nAChR. After the initial insertion event, a lateral spread
of fluorescence was observed corresponding to full fusion of the
vesicle and subsequent diffusion of the labeled receptors. We
counted insertion events in cells expressing ␣4␤2, ␣4␤2␣5, or
JOURNAL OF BIOLOGICAL CHEMISTRY
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ously (42) using nitrogen cavitation. Biased transfections were
performed by adding unequal amounts of ␣4-gfp and ␤2-wt
plasmid during the transfection of HEK-293T cells. These control studies were completed using 10:1, 4:1, and 1:4 ratios of
␣4-gfp to ␤2-wt plasmid. Equal amounts of plasmid were used
for all other studies. Vesicles were immobilized on clean glass
bottom dishes functionalized with 1 mg/ml Biotin-PEG-Silane
(Laysan Bio, Inc.), 0.05 mg/ml NeutrAvidin (Thermo Scientific), and 1 g/ml biotinylated anti-GFP antibody. Single vesicles were spatially isolated and immobilized using the GFP in
the receptor binding to a substrate-immobilized anti-GFP antibody. Vesicles were imaged using TIRF microscopy while covered in 1 ml of PBS. TIRF microscopy limits excitation to within
⬃100 nm of the substrate surface, decreasing background fluorescence. Generating small enough vesicles limits the probability of capturing more than one receptor in a single vesicle. This
single molecule isolation, as well as immobilization of these
vesicles within the TIRF illumination, allows us to perform single receptor measurements. Control experiments using monomeric receptors showed that there was a low probability of having more than one receptor per isolated vesicle. Of the vesicles
generated via nitrogen cavitation, ⬃15% contain a receptor
(42). Each field of view was imaged for 500 frames at a frame
rate of 200 ms while undergoing continuous 488 nm excitation
with an intensity of 60 watt/cm2. Autofocus (Olympus ZDC2)
was used to minimize focal drift. Time traces of 4 ⫻ 4-pixel
regions of interest were generated using ImageJ with the Time
Trace Analyzer V3.0 plugin. Photobleaching steps were determined manually as described previously (42– 44). Previously, a
discrete bleaching step was confirmed to correspond to one
subunit (42, 43). Table 1 includes the number of accepted and
rejected spots as well as the complete raw observed distribution
of stoichiometry for each condition. Time traces showing continuous decrease in fluorescence intensity or indistinct number
of bleaching steps were rejected. GFP fails to mature a small
percentage of the time, leading to some subunits not exhibiting
typical fluorescence, which would result in the undercounting
of bleaching events (42, 44). To account for this, the probability
of observing one, two, or three photobleaching steps in the time
traces for each stoichiometry was calculated using a custom
MATLAB script by fitting data to a binomial distribution, using
the probability of GFP fluorescing equal to 0.90 (44). The agreement of theoretical and experimental data was determined
using a -squared goodness of fit analysis. The probability of
observing a specific number of photobleaching steps, for a
receptor with fixed number of subunits is calculated using

Cotinine-induced Changes in nAChRs

␣4␤2␣5-D398N as compared with those exposed to no drug or
1 M cotinine. Fig. 3B shows a representative series of images of
an insertion event, illustrating frames prior to insertion (Fig. 3B,
panel 1), during arrival of the vesicle shown as a burst of fluorescence (Fig. 3B, panel 2), followed by a lateral spread (Fig. 3B,
panels 3– 6) and diffusion across the membrane (Fig. 3B, panels
7–9). Cells treated with 1 M cotinine exhibited approximately
a 30% increase in the number of vesicles that contained ␣4␤2 as
compared with untreated cells (Fig. 3C). When the ␣5D or ␣5N
auxiliary subunit was coexpressed with ␣4 and ␤2 subunits,
there were no differences in the trafficking rate of nAChRs in
the presence of cotinine.
Cotinine Exposure Results in Preferential Assembly of
(␣4)2(␤2)3—Because nAChRs are pentameric, ␣4␤2 can assemble with either an (␣4)3(␤2)2 or an (␣4)2(␤2)3 stoichiometry.
We used a technique that our laboratory recently developed to
perform single molecule analysis of subunit stoichiometry by
spatially isolating nAChRs embedded in cell membrane-derived vesicles (42). We generated vesicles from cells expressing
␣4-gfp and ␤2-wt subunits. These vesicles were isolated on
glass substrates, and TIRF microscopy was used to visualize the
GFP fluorescence signal (Fig. 4A). We used single step photobleaching of GFP to identify the number of ␣4-gfp subunits in
each receptor. The number of bleaching steps corresponds to
the number of GFP-tagged subunits present and, therefore,
indicates the stoichiometry of the receptor (22, 44). Examples of
two bleaching steps (Fig. 4B) corresponding to two ␣4-gfp subunits and (␣4)2(␤2)3 stoichiometry, or three bleaching steps
(Fig. 4C) indicating (␣4)3(␤2)2 stoichiometry, are shown.

24406 JOURNAL OF BIOLOGICAL CHEMISTRY

We plotted the distribution of individual vesicles showing
one, two, or three bleaching steps. The total distribution of
observed bleaching steps including the total number of vesicles
accepted or rejected is included in Table 1. For cells not
exposed to any compound, binomial distributions weighted for
60% (␣4)3(␤2)2 and 40% (␣4)2(␤2)3 fit the observed distribution (Fig. 4D). Treatment with 500 nM nicotine altered the
stoichiometric distribution with a shift toward a higher percentage of receptors with the high sensitivity stoichiometry.
The distribution of nicotine-exposed cells was best fit for
binomial distributions weighted with 35% (␣4)3(␤2)2 and
65% (␣4)2(␤2)3 (Fig. 4E). We repeated these experiments
in the presence of 1 M cotinine. This also resulted in a
shift in the stoichiometric distribution toward (␣4)2(␤2)3.
The observed distribution fit to binomials weighted 30%
(␣4)3(␤2)2 and 70% (␣4)2(␤2)3 (Fig. 4F). Fig. 5 compares the
stoichiometries derived from the weighted fits (Fig. 4, d–f) of
␣4␤2 with no drug, nicotine, and cotinine. Exposure to either
nicotine or cotinine results in the preferential assembly of the
high sensitivity (␣4)2(␤2)3 receptor.
Previous studies have altered the primary stoichiometry of
␣4␤2 expressed using biased transfection, with one subunit
expressed at higher levels than the other (4, 5, 19, 46). These
types of studies have primarily used Xenopus oocyte expression
systems with changes in stoichiometry determined from
changes in the biphasic dose response based on whole cell current measurements. To verify our observations of nicotine- and
cotinine-induced changes in (␣4)3(␤2)2 stoichiometry, we performed stoichiometry measurements with biased transfection
VOLUME 290 • NUMBER 40 • OCTOBER 2, 2015
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FIGURE 1. TIRFM images illustrating increased ␣4␤2 PMID with nicotine or cotinine exposure. A–C, representative TIRFM images of ␣4-sep ␤2-wt with no
drug (A), 500 nM nicotine (B), or 1 M cotinine (C). The first column shows respective cells at pH 7.4 with receptors on the plasma membrane and endoplasmic
reticulum fluorescing, whereas the second column shows the same cells at pH 5.4 with all fluorescence from receptors in the endoplasmic reticulum. The third
column shows images constructed by subtracting the pH 5.4 image from the pH 7.4 image, resulting in receptors located on the plasma membrane (PMID).

Cotinine-induced Changes in nAChRs
treatment was increased to 1 M cotinine and was lost at 5 M
cotinine as PMID is comparable with ␣6␤2␤3 with no drug.
Cotinine Does Not Alter Density or Trafficking of ␣6␤2,
␣4␤2␣5, or ␣3␤4 receptors—Although ␣6␤2␤3 exhibited
down-regulation as a result of cotinine exposure, we found that
cotinine had no effect on the membrane expression of ␣6␤2.
SEP-based studies show no significant differences in PM integrated density or the percentage expressed on the plasma membrane for ␣6␤2 exposed to cotinine (Fig. 8A). Likewise, PMID
and % PM of ␣4␤2␣5, ␣4␤2␣5-D398N (Fig. 8, B–D), ␣3␤4,
␣3␤4␣5, and ␣3␤4␣5-D398N (Fig. 9) did not change upon the
addition of 500 nM nicotine or 1 M cotinine, although we did
observe a cotinine-independent difference in the distribution of
␣4␤2␣5-398N as compared with 398D with an increase in the
fraction of observable receptors on the plasma membrane as
compared with the peripheral ER.

ratios of 10:1, 4:1, 1:1, and 1:4 (␣4:␤2). Single molecule analysis
showed that the fraction of (␣4)3(␤2)2 reduced and the fraction
of (␣4)2(␤2)3 increased when higher levels of ␤2 were transfected (1:4 (␣4:␤2)) (Fig. 6).
Low Concentrations of Cotinine Decrease ␣6␤2␤3 Receptor
Density on the PM—We also evaluated the effect of cotinine on
the expression of ␣6␤2 and ␣6␤2␤3 nAChRs. Matching previous studies (7), our data also show that incorporation of the ␤3
subunit into an ␣6␤2 pentamer results in increased expression
levels on the PM (Fig. 7; p ⬍ 0.05). Once ␤3 is included in the
pentamer, there appears to be a cotinine concentration-dependent response resulting in lower levels of ␣6␤2␤3 nAChR on
the plasma membrane. At low levels of cotinine (100 nM), there
is a trend toward a decreased number of ␣6␤2␤3 nAChRs,
reaching significance with 500 nM cotinine (Fig. 7; p ⬍ 0.05).
The down-regulated level of expression of ␣6␤2␤3 with 500 nM
cotinine is comparable with that of ␣6␤2 when the ␤3 subunit is
absent. Down-regulation was less pronounced when cotinine
OCTOBER 2, 2015 • VOLUME 290 • NUMBER 40
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FIGURE 2. Cotinine-induced up-regulation of ␣4␤2. A, quantification of
␣4␤2 PMID (A) shows an up-regulation of ␣4␤2 receptors with exposure to as
little as 100 nM cotinine. a. u., arbitrary units. B, cotinine also alters the distribution of receptors within the field of view, as shown by an increase in % PM
for ␣4␤2 in N2a cells treated with cotinine (n ⫽ 40, 21, 21, 23, 13) Data are
mean values ⫾ S.E. (**, p ⬍ 0.01, ***, p ⬍ 0.001).

Discussion
It is well established that chronic nicotine exposure up-regulates and alters the assembly of ␣4␤2 nAChRs (10 –12, 47), but
the effects of nicotine metabolites on nAChR assembly and trafficking are not well studied. We exposed cells to physiologically
relevant levels of cotinine matching the average reported values
of cotinine in a smoker’s blood, urine, or brain (48 –50). Our
data show that cotinine up-regulates ␣4␤2 nAChRs at concentrations of 1 M cotinine, which corresponds to the average
concentration of cotinine in the blood of a typical smoker (48).
Cotinine induces significant increases in both ␣4␤2 PMID and
% PM at as little as 100 nM. This suggests that cotinine could
potentially contribute to ␣4␤2 up-regulation in smokers
because brain concentrations of cotinine are estimated to be
⬃300 nM (28). However, at higher concentrations of cotinine,
this up-regulation effect is lost, suggesting a secondary effect
that depresses PM expression. Cotinine acts as a partial agonist
of nAChRs, activating channels at higher concentrations. It has
also been shown that nAChR ligands at higher concentrations
can result in endocytosis (51). The highest concentrations (10
M) used in our studies may be sufficient to cause endocytosis
of ␣4␤2 nAChRs, resulting in a decrease of observed receptors
on the PM.
Due to the observed increase in the number of ␣4␤2 receptors located on the plasma membrane, we speculated that the
increase in receptors at lower concentrations of cotinine could
be partially due to an increase in the trafficking of receptors to
the PM. We found that 1 M cotinine increases the number of
single vesicle insertion events, which suggests that cotinine,
similar to nicotine, increases the trafficking of ␣4␤2 from the
ER to the PM. Therefore, the higher PMID and % PM levels
resulting from cotinine exposure are at least partially the result
of increased frequency of insertion of vesicles containing ␣4␤2
receptors.
It has also been shown that nicotine exposure results in a
preferential assembly of high sensitivity ␣4␤2 receptors with an
(␣4)2(␤2)3 stoichiometry (22). In the absence of nicotine or
cotinine, the fifth position of the pentamer slightly favors occupation by an ␣ subunit. In the presence of cotinine or nicotine,
␣4␤2 preferentially assembles the high sensitivity (␣4)2(␤2)3
stoichiometry. This alteration does not require surface recep-
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FIGURE 3. Increased number of ␣4␤2 single vesicle insertion events when exposed to 1 M cotinine. A, TIRFM image of an N2a transfected with ␣4-sep
␤2-wt exposed to 1 M cotinine (cot). Images were collected at a 200-ms frame rate and analyzed over 10 s. An example of an insertion event is shown in B,
where panel 1 is the frame before the insertion and panel 2 shows vesicle arrival, followed by a lateral spread (panels 3– 6) and diffusion across the membrane
(panels 7–9). C, insertion events were counted for ␣4-sep ␤2-wt, ␣4-sep ␤2-wt ␣5-wt, or ␣4-sep ␤2-wt ␣5-D398N with or without exposure to 1 M cotinine for
48 h, showing an increase in frequency in insertion for ␣4␤2 exposed to cotinine. (n ⫽ 5) Data are mean values ⫾ S.E. (**, p ⬍ 0.01).

tor-activating concentrations of nicotine, but is thought to be
linked to the mechanism of nicotine addiction.
Changes in nAChR number, stoichiometry, and trafficking
are well established consequences of exposure to nicotine (8,
10, 12, 36, 47). It is possible that cotinine-induced up-regulation
results from a similar mechanism as nicotine, likely acting
inside the cell by binding immature subunits to enhance the
maturation and stabilization of nAChRs (18, 52). This chaperoning process is not unique to nicotine, and can potentially
occur with any ligand that readily permeates cell membranes
and interacts with intracellular nAChRs. This is consistent with
our observations of nAChRs exposed to cotinine, which is a
partial agonist of ␣4␤2 (31, 53).
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In the case of nicotine, up-regulation is subtype-specific. It
appears that subtypes with a higher basal PM density are not
subjected to nicotine-induced up-regulation, possibly because
receptor transport is already efficient. For instance, basal levels
of ␣3␤4 nAChRs are three times higher than ␤2-containing
nAChRs and have not been shown to up-regulate when exposed
to concentrations of nicotine seen in smokers (14, 36), but can
up-regulate at much higher concentrations (13). If cotinine
affects nAChRs in a similar mechanism, ␣3␤4 may not be upregulated by cotinine because of the already high levels of PM
expression.
Although ␣4␤2 shows clear up-regulation when exposed to
nicotine, contradicting results have been reported for ␣6␤2*,
VOLUME 290 • NUMBER 40 • OCTOBER 2, 2015
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TABLE 1
Total distribution of observed bleaching steps including the total number of spots accepted and rejected as well as the number of one-, two-,
three-, and four-step bleaching events observed for all three conditions
No drug
⫹ Cotinine (1 M)
⫹ Nicotine (500 nM)

No. of vesicles

One step

Two steps

Three steps

Four steps

Rejected

903
782
800

28
47
40

171
194
202

160
64
83

12
10
11

532
467
464

FIGURE 5. Drug-induced changes in assembly of ␣4␤2. Nicotine and cotinine exposure causes a higher percentage of ␣4␤2 nAChRs to be assembled
with (␣4)2(␤2)3 stoichiometry. When no drug is present, 40% of ␣4␤2 has
(␣4)2(␤2)3 stoichiometry, whereas 60% has (␣4)3(␤2)2. This distribution is
changed to 65% (␣4)2(␤2)3 and 35% (␣4)3(␤2)2 in the presence of nicotine
and 70% (␣4)2(␤2)3 and 30% (␣4)3(␤2)2 in the presence of cotinine.

with claims of up-regulation, down-regulation, or no change
when chronically exposed to nicotine (54 –56). These discrepancies may be due to the presence or absence of the auxiliary ␤3
subunit and a dose-dependent response of ␣6␤2␤3 to nicotine
(7). Our data also show that the incorporation of a ␤3 auxiliary
OCTOBER 2, 2015 • VOLUME 290 • NUMBER 40

FIGURE 6. Biased transfection as a control for changes in stoichiometry.
The ratios listed on the x axis represent the transfected ratio of (␣4:␤2). Biased
transfection at a 1:4 ratio (␣4:␤2) resulted in a clear shift toward the (␣4)2(␤2)3
stoichiometry (65%) as compared with unbiased transfection, which results in
40% (␣4)2(␤2)3 based on the distribution of single receptor bleaching steps.
Biased transfection of 4:1 toward ␣4 did not result in changes in the distribution of stoichiometries as compared with unbiased transfection. However,
biased transfection of 10:1 toward ␣4 did shift the stoichiometry toward the
(␣4)3(␤2)2 stoichiometry from 60% when unbiased to 70% when biased.

subunit resulted in higher levels of expression on the PM as
compared with ␣6␤2 alone, as well as a dose-dependent downregulation of ␣6␤2␤3 in the presence of cotinine. Recent eviJOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 4. Cotinine exposure results in preferential assembly of (␣4)2(␤2)3. A, cell-derived vesicles containing a single nAChR were isolated and immobilized on a glass coverslip and then imaged using TIRFM. Because one fluorophore corresponds to the presence of one GFP-tagged subunit in an assembled
receptor, the number of bleaching steps corresponds to the number of ␣-GFP subunits. B, time traces for two bleaching steps correspond to the presence of
2 ␣4-gfp subunits, and thus to (␣4)2(␤2)3 stoichiometry. C, three bleaching steps correspond to (␣4)3(␤2)2 stoichiometry. Observed and fitted distributions of
number of bleaching steps for ␣4-gfp/␤2-wt are shown. D, no drug exposure results in nearly equal amounts of (␣4)2(␤2)3 and (␣4)3(␤2)2 stoichiometry. E and
F, exposure to nicotine alters this distribution to 65% (␣4)2(␤2)3 and 35% (␣4)3(␤2)2 stoichiometry (E), whereas cotinine exposure results in a 70% (␣4)2(␤2)3 and
30% (␣4)3(␤2)2 distribution (F). The error bars for subunit distribution are based on counting events and are calculated as the square root of the counts.
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FIGURE 9. Nicotine and cotinine do not affect trafficking of ␣3␤4. A and
B, no changes in number (A) or distribution (B) of ␣3␤4, ␣3␤4␣5, or
␣3␤4␣5D398N were seen when exposed to 500 nM nicotine (Nic, n ⫽ 13, 14,
11, 11, 4, 8). a. u., arbitrary units. C and D, exposure to 1 M cotinine (Cot) also
resulted in no changes in ␣3␤4, ␣3␤4␣5, or ␣3␤4␣5D398N PMID (C) or % PM
(D) (n ⫽ 13, 14, 11, 7, 4, 18). Data are mean values ⫾ S.E.

partially explain discrepancies between groups that detect upregulation (7, 55, 56) or down-regulation (57) in varying brain
regions based on concentrations of nicotine or cotinine
present.
These studies show that nicotine’s primary metabolite, cotinine, has a similar effect on the trafficking and assembly of
nAChRs as seen with nicotine. Cotinine has a longer half-life
and higher sustained concentration than nicotine in the human
body. It is possible that variations in the concentration of cotinine resulting from gene variation and clearance rates in different ethnicities could account for some differences in rates of
nicotine addiction.

FIGURE 8. Cotinine does not affect ␣6␤2- or ␣5-containing nAChRs. A,
cotinine does not alter the expression of ␣6␤2 (n ⫽ 18, 11, 9, 18, 8). a. u.,
arbitrary units. B and C, incorporation of ␣5 results in loss of up-regulation
after treatment with cotinine in terms of number of receptors (C) and distribution toward the membrane (B) (n ⫽ 19, 21, 20, 10, 37). D, the distribution of
receptors containing an ␣5-D398N subunit is altered to a higher % PM,
regardless of the concentration of cotinine, whereas the number of receptors
remains unchanged (n ⫽ 14, 23, 26, 33, 24, 30). Data are mean values ⫾ S.E. (**,
p ⬍ 0.01).

dence suggests that a KKK motif within the ␤3 subunit plays a
regulatory role in ␣6␤2* expression (7). This motif is essential
for nicotine-induced up-regulation of ␣6␤2␤3, possibly acting
as a recognition site for COPI binding (7). Cotinine potentially
differs in its interaction with the KKK motif as compared with
nicotine. Interestingly, another study has shown that cotinine
only interacts with a subset of ␣6␤2*, whereas the entire population is sensitive to nicotine (53). The lack of cotinine-induced
up-regulation of ␣6␤2␤3 is potentially related to its action on
only a portion of this receptor population. This effect could also

24410 JOURNAL OF BIOLOGICAL CHEMISTRY

Author Contributions—A. M. F. and C. I. R. designed the studies and
wrote the paper. A. M. F and F. H. M. performed the experiments.
F. H. M. wrote the analysis software for the single molecule studies.
All authors reviewed the results and approved the final version of the
manuscript.
References
1. Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., and Rogers, S. W.
(2009) Mammalian nicotinic acetylcholine receptors: from structure to
function. Physiol. Rev. 89, 73–120
2. Anand, R., Conroy, W. G., Schoepfer, R., Whiting, P., and Lindstrom, J.
(1991) Neuronal nicotinic acetylcholine-receptors expressed in Xenopus
oocytes have a pentameric quaternary structure. J. Biol. Chem. 266,
11192–11198
3. Lukas, R. J., Changeux, J. P., Le Novère, N., Albuquerque, E. X., Balfour,
D. J., Berg, D. K., Bertrand, D., Chiappinelli, V. A., Clarke, P. B., Collins,
A. C., Dani, J. A., Grady, S. R., Kellar, K. J., Lindstrom, J. M., Marks, M. J.,
Quik, M., Taylor, P. W., and Wonnacott, S. (1999) International Union of
Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacol. Rev. 51, 397– 401
4. Zwart, R., and Vijverberg, H. P. (1998) Four pharmacologically distinct
subtypes of ␣4␤2 nicotinic acetylcholine receptor expressed in Xenopus

VOLUME 290 • NUMBER 40 • OCTOBER 2, 2015

Downloaded from http://www.jbc.org/ by guest on December 1, 2016

FIGURE 7. Cotinine-induced down-regulation of ␣6␤2␤3. Quantification
of PMID for ␣6␤2␤3 as compared with a control with no ␤3 subunit, ␣6␤2,
shows a significant increase in the number of receptors on the membrane
when ␤3 is incorporated into the ␣6␤2 pentamer. When ␤3 is present, 500 nM
cotinine significantly decreases the PMID, with a trend toward down-regulation at 100 nM cotinine. Down-regulation is less pronounced when cotinine
treatment was increased to 1 M cotinine and is lost at 5 M cotinine as PMID
is comparable with ␣6␤2␤3 with no drug (n ⫽ 19, 27, 16, 11, 11). Data are
mean values ⫾ S.E. (*, p ⬍ 0.05 as compared with control of ␣6␤2; #, p ⬍ 0.05
as compared with control of ␣6␤2␤3 with no drug). a. u., arbitrary units.

Cotinine-induced Changes in nAChRs

OCTOBER 2, 2015 • VOLUME 290 • NUMBER 40

tinic acetylcholine receptors. ACS Chem. Biol. 9, 1153–1159
24. Mazzaferro, S., Benallegue, N., Carbone, A., Gasparri, F., Vijayan, R., Biggin, P. C., Moroni, M., and Bermudez, I. (2011) Additional acetylcholine
(ACh) binding site at ␣4/␣4 interface of (␣4␤2)2␣4 nicotinic receptor
influences agonist sensitivity. J. Biol. Chem. 286, 31043–31054
25. Nashmi, R., Xiao, C., Deshpande, P., McKinney, S., Grady, S. R., Whiteaker, P., Huang, Q., McClure-Begley, T., Lindstrom, J. M., Labarca, C.,
Collins, A. C., Marks, M. J., and Lester, H. A. (2007) Chronic nicotine cell
specifically upregulates functional ␣4* nicotinic receptors: basis for both
tolerance in midbrain and enhanced long-term potentiation in perforant
path. J. Neurosci. 27, 8202– 8218
26. Govind, A. P., Vezina, P., and Green, W. N. (2009) Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to
nicotine addiction. Biochem. Pharmacol. 78, 756 –765
27. Moran, V. E. (2012) Cotinine: beyond that expected, more than a biomarker of tobacco consumption. Front. Pharmacol. 3, 173
28. Buccafusco, J. J., and Terry, A. V. (2003) The potential role of cotinine in
the cognitive and neuroprotective actions of nicotine. Life Sci. 72,
2931–2942
29. Echeverria, V., and Zeitlin, R. (2012) Cotinine: a potential new therapeutic
agent against Alzheimer’s disease. CNS Neurosci. Ther. 18, 517–523
30. Riah, O., Courrière, P., Dousset, J.-C., Todeschi, N., and Labat, C. (1998)
Nicotine is more efficient than cotinine at passing the blood-brain barrier
in rats. Cell. Mol. Neurobiol. 18, 311–318
31. Vainio, P. J., and Tuominen, R. K. (2001) Cotinine binding to nicotinic
acetylcholine receptors in bovine chromaffin cell and rat brain membranes. Nicotine Tob. Res. 3, 177–182
32. Terry, A. V., Jr., Hernandez, C. M., Hohnadel, E. J., Bouchard, K. P., and
Buccafusco, J. J. (2005) Cotinine, a neuroactive metabolite of nicotine:
potential for treating disorders of impaired cognition. CNS Drug Rev. 11,
229 –252
33. Benowitz, N. L., Hukkanen, J., and Jacob, P., 3rd. (2009) Nicotine chemistry, metabolism, kinetics and biomarkers. Handb. Exp. Pharmacol. 2009,
29 – 60, 10.1007/978-3-540-69248-5_2
34. Terry, A. V., Jr., Callahan, P. M., and Bertrand, D. (2015) R-(⫹) and S-(⫺)
isomers of cotinine augment cholinergic responses in vitro and in vivo.
J. Pharmacol. Exp. Ther. 352, 405– 418
35. Grizzell, J. A., and Echeverria, V. (2014) New insights into the mechanisms
of action of cotinine and its distinctive effects from nicotine. Neurochem.
Res. 10.1007/s11064 – 014-1359 –2
36. Richards, C. I., Srinivasan, R., Xiao, C., Mackey, E. D. W., Miwa, J. M., and
Lester, H. A. (2011) Trafficking of ␣4* nicotinic receptors revealed by
superecliptic phluorin. J. Biol. Chem. 286, 31241–31249
37. Frahm, S., Slimak, M. A., Ferrarese, L., Santos-Torres, J., Antolin-Fontes,
B., Auer, S., Filkin, S., Pons, S., Fontaine, J. F., Tsetlin, V., Maskos, U., and
Ibañez-Tallon, I. (2011) Aversion to nicotine is regulated by the balanced
activity of ␤4 and ␣5 nicotinic receptor subunits in the medial habenula.
Neuron 70, 522–535
38. Mattheyses, A. L., Simon, S. M., and Rappoport, J. Z. (2010) Imaging with
total internal reflection fluorescence microscopy for the cell biologist.
J. Cell Sci. 123, 3621–3628
39. Yudowski, G. A., Puthenveedu, M. A., Leonoudakis, D., Panicker, S.,
Thorn, K. S., Beattie, E. C., and von Zastrow, M. (2007) Real-time imaging
of discrete exocytic events mediating surface delivery of AMPA receptors.
J. Neurosci. 27, 11112–11121
40. Paroutis, P., Touret, N., and Grinstein, S. (2004) The pH of the secretory
pathway: measurement, determinants, and regulation. Physiology (Bethesda) 19, 207–215, 10.1152/physiol.00005.2004
41. Khiroug, S. S., Pryazhnikov, E., Coleman, S. K., Jeromin, A., Keinanen, K.,
and Khiroug, L. (2009) Dynamic visualization of membrane-inserted fraction of pHluorin-tagged channels using repetitive acidification technique.
BMC Neurosci. 10, 141
42. Moonschi, F. H., Effinger, A. K., Zhang, X., Martin, W. E., Fox, A. M.,
Heidary, D. K., DeRouchey, J. E., and Richards, C. I. (2015) Cell-derived
vesicles for single-molecule imaging of membrane proteins. Angew. Chem.
Int. Ed. Engl. 54, 481– 484
43. Das, S. K., Liu, Y., Yeom, S., Kim, D. Y., and Richards, C. I. (2014)
Single-particle fluorescence intensity fluctuations of carbon nanodots.

JOURNAL OF BIOLOGICAL CHEMISTRY

24411

Downloaded from http://www.jbc.org/ by guest on December 1, 2016

laevis oocytes. Mol. Pharmacol. 54, 1124 –1131
5. Moroni, M., Zwart, R., Sher, E., Cassels, B. K., and Bermudez, I. (2006)
␣4␤2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine. Mol. Pharmacol. 70, 755–768
6. Miwa, J. M., Freedman, R., and Lester, H. A. (2011) Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron
70, 20 –33
7. Henderson, B. J., Srinivasan, R., Nichols, W. A., Dilworth, C. N., Gutierrez,
D. F., Mackey, E. D. W., McKinney, S., Drenan, R. M., Richards, C. I., and
Lester, H. A. (2014) Nicotine exploits a COPI-mediated process for chaperone-mediated up-regulation of its receptors. J. Gen. Physiol. 143, 51– 66
8. Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R.,
Banghart, M. R., Dougherty, D. A., Goate, A. M., and Wang, J. C. (2009)
Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery. AAPS J.
11, 167–177
9. Tapia, L., Kuryatov, A., and Lindstrom, J. (2007) Ca2⫹ permeability of the
(␣4)3(␤2)2 stoichiometry greatly exceeds that of (␣4)2(␤2)3 human acetylcholine receptors. Mol. Pharmacol. 71, 769 –776
10. Colombo, S. F., Mazzo, F., Pistillo, F., and Gotti, C. (2013) Biogenesis,
trafficking and up-regulation of nicotinic ACh receptors. Biochem. Pharmacol. 86, 1063–1073
11. Marks, M. J., Burch, J. B., and Collins, A. C. (1983) Effects of chronic
nicotine infusion on tolerance development and nicotinic receptors.
J. Pharmacol. Exp. Ther. 226, 817– 825
12. Marks, M. J., Grady, S. R., Salminen, O., Paley, M. A., Wageman, C. R.,
McIntosh, J. M., and Whiteaker, P. (2014) ␣6␤2*-subtype nicotinic acetylcholine receptors are more sensitive than ␣4␤2*-subtype receptors to
regulation by chronic nicotine administration. J. Neurochem. 130,
185–198
13. Mazzo, F., Pistillo, F., Grazioso, G., Clementi, F., Borgese, N., Gotti, C., and
Colombo, S. F. (2013) Nicotine-modulated subunit stoichiometry affects
stability and trafficking of ␣3␤4 nicotinic receptor. J. Neurosci. 33,
12316 –12328
14. Srinivasan, R., Pantoja, R., Moss, F. J., Mackey, E. D. W., Son, C., Miwa, J.,
and Lester, H. A. (2011) Nicotine upregulates ␣4␤2 nicotinic receptors
and ER exit sites via stoichiometry-dependent chaperoning. J. Gen.
Physiol. 137, 59 –79
15. Lomazzo, E., Hussmann, G. P., Wolfe, B. B., Yasuda, R. P., Perry, D. C., and
Kellar, K. J. (2011) Effects of chronic nicotine on heteromeric neuronal
nicotinic receptors in rat primary cultured neurons. J. Neurochem. 119,
153–164
16. Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., and Lindstrom, J. (2003)
Alternate stoichiometries of ␣4␤2 nicotinic acetylcholine receptors. Mol.
Pharmacol. 63, 332–341
17. Changeux, J. P. (2010) Nicotine addiction and nicotinic receptors: lessons
from genetically modified mice. Nat. Rev. Neurosci. 11, 389 – 401
18. Srinivasan, R., Henderson, B. J., Lester, H. A., and Richards, C. I. (2014)
Pharmacological chaperoning of nAChRs: A therapeutic target for Parkinson’s disease. Pharmacol. Res. 83, 20 –29
19. Srinivasan, R., Richards, C. I., Dilworth, C., Moss, F. J., Dougherty, D. A.,
and Lester, H. A. (2012) Forster resonance energy transfer (FRET) correlates of altered subunit stoichiometry in Cys-loop receptors, exemplified
by nicotinic ␣4␤2. Int. J. Mol. Sci. 13, 10022–10040
20. Turner, J. R., Castellano, L. M., and Blendy, J. A. (2011) Parallel anxiolyticlike effects and upregulation of neuronal nicotinic acetylcholine receptors
following chronic nicotine and varenicline. Nicotine Tob. Res. 13, 41– 46
21. Pauly, J. R., Marks, M. J., Robinson, S. F., van de Kamp, J. L., and Collins,
A. C. (1996) Chronic nicotine and mecamylamine treatment increase
brain nicotinic receptor binding without changing ␣4 or ␤2 mRNA levels.
J. Pharmacol. Exp. Ther. 278, 361–369
22. Richards, C. I., Luong, K., Srinivasan, R., Turner, S. W., Dougherty, D. A.,
Korlach, J., and Lester, H. A. (2012) Live-cell imaging of single receptor
composition using zero-mode waveguide nanostructures. Nano Lett. 12,
3690 –3694
23. Marotta, C. B., Rreza, I., Lester, H. A., and Dougherty, D. A. (2014) Selective ligand behaviors provide new insights into agonist activation of nico-

Cotinine-induced Changes in nAChRs

24412 JOURNAL OF BIOLOGICAL CHEMISTRY

51. St John, P. A., and Gordon, H. (2001) Agonists cause endocytosis of nicotinic acetylcholine receptors on cultured myotubes. J. Neurobiol. 49,
212–223
52. Henderson, B. J., and Lester, H. A. (2015) Inside-out neuropharmacology
of nicotinic drugs. Neuropharmacology 96, 178 –193
53. O’Leary, K., Parameswaran, N., McIntosh, J. M., and Quik, M. (2008)
Cotinine selectively activates a subpopulation of ␣3/␣6␤2 nicotinic receptors in monkey striatum. J. Pharmacol. Exp. Ther. 325, 646 – 654
54. Tumkosit, P., Kuryatov, A., Luo, J., and Lindstrom, J. (2006) ␤3 subunits
promote expression and nicotine-induced up-regulation of human nicotinic ␣6* nicotinic acetylcholine receptors expressed in transfected cell
lines. Mol. Pharmacol. 70, 1358 –1368
55. Perez, X. A., Bordia, T., McIntosh, J. M., Grady, S. R., and Quik, M. (2008)
Long-term nicotine treatment differentially regulates striatal ␣6␣4␤2*
and ␣6(non␣4)␤2* nAChR expression and function. Mol. Pharmacol. 74,
844 – 853
56. Walsh, H., Govind, A. P., Mastro, R., Hoda, J. C., Bertrand, D., Vallejo, Y.,
and Green, W. N. (2008) Upregulation of nicotinic receptors by nicotine
varies with receptor subtype. J. Biol. Chem. 283, 6022– 6032
57. Perry, D. C., Mao, D., Gold, A. B., McIntosh, J. M., Pezzullo, J. C., and
Kellar, K. J. (2007) Chronic nicotine differentially regulates ␣6- and ␤3containing nicotinic cholinergic receptors in rat brain. J. Pharmacol. Exp.
Ther. 322, 306 –315

VOLUME 290 • NUMBER 40 • OCTOBER 2, 2015

Downloaded from http://www.jbc.org/ by guest on December 1, 2016

Nano Lett. 14, 620 – 625
44. Ulbrich, M. H., and Isacoff, E. Y. (2007) Subunit counting in membranebound proteins. Nat. Methods 4, 319 –321
45. Araki, Y., Lin, D. T., and Huganir, R. L. (2010) Plasma membrane
insertion of the AMPA receptor GluA2 subunit is regulated by NSF
binding and Q/R editing of the ion pore. Proc. Natl. Acad. Sci. U.S.A.
107, 11080 –11085
46. Govind, A. P., Walsh, H., and Green, W. N. (2012) Nicotine-induced upregulation of native neuronal nicotinic receptors is caused by multiple
mechanisms. J. Neurosci. 32, 2227–2238
47. Kuryatov, A., Luo, J., Cooper, J., and Lindstrom, J. (2005) Nicotine acts as
a pharmacological chaperone to up-regulate human ␣4␤2 acetylcholine
receptors. Mol. Pharmacol. 68, 1839 –1851
48. Vine, M. F., Hulka, B. S., Margolin, B. H., Truong, Y. K., Hu, P.-C., Schramm, M. M., Griffith, J. D., McCann, M., and Everson, R. B. (1993) Cotinine concentrations in semen, urine, and blood of smokers and nonsmokers. Am. J. Public Health 83, 1335–1338
49. Ghosheh, O., Dwoskin, L. P., Li, W.-K., and Crooks, P. A. (1999) Residence
times and half-lives of nicotine metabolites in rat brain after acute peripheral administration. Drug Metab. Dispos. 27, 1448 –1455
50. Caraballo, R. S., Giovino, G. A., Pechacek, T. F., Mowery, P. D., Richter,
P. A., Strauss, W. J., Sharp, D. J., Eriksen, M. P., Pirkle, J. L., and Maurer,
K. R. (1998) Racial and ethnic differences in serum cotinine levels of cigarette smokers. JAMA 280, 135–139

The Nicotine Metabolite, Cotinine, Alters the Assembly and Trafficking of a Subset
of Nicotinic Acetylcholine Receptors
Ashley M. Fox, Faruk H. Moonschi and Christopher I. Richards
J. Biol. Chem. 2015, 290:24403-24412.
doi: 10.1074/jbc.M115.661827 originally published online August 12, 2015

Access the most updated version of this article at doi: 10.1074/jbc.M115.661827
Alerts:
• When this article is cited
• When a correction for this article is posted

This article cites 57 references, 30 of which can be accessed free at
http://www.jbc.org/content/290/40/24403.full.html#ref-list-1

Downloaded from http://www.jbc.org/ by guest on December 1, 2016

Click here to choose from all of JBC's e-mail alerts

